ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,262.75
-0.15%
Dow Jones
38,318.74
-0.95%
Gold vs US Dollar
2,343.77
0.77%
Brent Oil
78.405
-2.97%
Bitcoin
69,229.46
2.19%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Sage Therapeutics Inc (SAGE) Share Price

SAGE Sage Therapeutics Inc

11.22
0.11 (0.99%)
Last Updated: 17:09:39
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Sage Therapeutics Inc NASDAQ:SAGE NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.11 0.99 11.22 11.21 11.23 11.67 11.09 11.18 200,452 16:09:39   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 86.46M -541.49M -9.0088 -1.27 685.82M
 Type  Size  Price  Time  Units 
 9 21 11.21 16:11:05 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore SAGE News
07/05/202411:30BWSage Therapeutics to Participate in Upcoming May Investor Conferences
25/04/202411:30BWSage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
17/04/202411:30BWSage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease
11/04/202411:30BWSage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024
28/02/202411:30BWSage Therapeutics to Present at Upcoming March Investor Conferences
21/02/202421:35EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
15/02/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
28/11/202110:00PBBTHE OMICRON anagram is MORONIC..DONT BE FOOLED by this bullshit!3
27/04/202123:39PBBSAGE ADVISOR COMMIE STALINIST BITCH SUSAN MICHIE...READ THE FACTS!1
29/04/202009:30PBBGOVT SAGE CLANDESTINE GROUP ..READ THE SHOCKING FACTS RE COVID1
Data Downloads for SAGE

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Sage Therapeutics Inc Articles